Earlier this month, Merck and Daiichi Sankyo announced that ifinatamab deruxtecan was granted Breakthrough Therapy Designation by the U.S. FDA for treating adult patients with extensive-stage small ...

However, AbbVie has also built a substantial oncology franchise with products like Imbruvica and Venclexta. Some key oncology ...

The two trading partners documented provisions of a deal that would set a 15% tariff on many EU imports, including cars, auto ...